Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma - SiliconANGLE

Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery

Chai Discovery is raising $400M at a $3.4B valuation for AI drug discovery, backed by Pfizer, Eli Lilly, and OpenAI, raising questions for crypto's DeSci